Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biology of Reproduction|April 16, 2004
Mitogen-activated protein kinase dynamics during the meiotic G2/MI transition of mouse spermatocytesAmy Inselman, Mary Ann Handel
Neurotoxicology|December 9, 2019
Potential mechanisms for phencyclidine/ketamine-induced brain structural alterations and behavioral consequencesCheng Wang, Amy Inselman, Shuliang Liu, et al.
Chromosoma|September 7, 2004
SUMO modified proteins localize to the XY body of pachytene spermatocytesRichard S Rogers, Amy Inselman, Mary Ann Handel, et al.
EMBO Reports|March 20, 2004
A new role for the mitotic RAD21/SCC1 cohesin in meiotic chromosome cohesion and segregation in the mouseHuiling Xu, Matthew Beasley, Sandra Verschoor, et al.
The Journal of Biological Chemistry|March 25, 2004
Reductions in linker histone levels are tolerated in developing spermatocytes but cause changes in specific gene expressionQingcong Lin, Amy Inselman, Xing Han, et al.
Birth Defects Research|May 6, 2026
Potential Effects of Prepubertal Exposure to Perfluorooctane Sulfonic Acid on the First Wave of Folliculogenesis in Young CD-1 MiceBounleut Phanavanh, Jalina Moore, Amy Inselman, et al.
Developmental Biology|February 1, 2002
The mouse meiotic mutation mei1 disrupts chromosome synapsis with sexually dimorphic consequences for meiotic progressionBrian J Libby, Rabindranath De La Fuente, Marilyn J O'Brien, et al.
Frontiers in Neuroscience|April 24, 2015
Effects of silver nanoparticles on human and rat embryonic neural stem cellsFang Liu, Meena Mahmood, Yang Xu, et al.
Pharmaceutical Biology|April 28, 2026
A screening strategy for identifying the developmental and reproductive toxicity potential of botanicalsCatherine Mahony, Arianna Bartlett, Suzanne Fitzpatrick, et al.
Disease Models & Mechanisms|April 25, 2022
The benefits, limitations and opportunities of preclinical models for neonatal drug developmentSarah Campion, Amy Inselman, Belinda Hayes, et al.
Pageof 2